申请人:——
公开号:US20040019064A1
公开(公告)日:2004-01-29
Novel pyridopyrimidine derivatives which have a binding affinity for the human 5-HT
6
receptor and, therefore, are useful in treating disorders responsive to antagonism of the 5-HT
6
receptor such as psychosis, schizophrenia, manic depression, depression, neurological disorder, memory disorder, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease and Huntington's chorea.
新型吡啶吡嘧啶衍生物具有与人类5-HT6受体结合亲和力,因此可用于治疗对5-HT6受体拮抗作用敏感的疾病,如精神病、精神分裂症、躁郁症、抑郁症、神经障碍、记忆障碍、帕金森病、肌萎缩侧索硬化、阿尔茨海默病和亨廷顿舞蹈症。